- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
Cytokeratin-5 Antibody (C-term)Rabbit Monoclonal Antibody
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AJ1227c | 100ul 400 ul | 2-3 days | $ 315.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
Cytokeratin-5 Antibody (C-term) - Product info | |
| Application | WB, IHC, IF
|
| Primary Accession | P13647 |
| Reactivity | Human |
| Clone Names | EP1601Y |
| Calculated MW | 62378 Da |
| Gene ID 3852 | |
| Other Names KRT5, Keratin, type II cytoskeletal 5, 58 kDa cytokeratin | |
| Target/Specificity A synthetic peptide corresponding to residues on the C-terminus of human CK-5 was used as an immunogen. | |
| Dilution WB~~1:10000~50000 IHC~~1:100~250 | |
| Format 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions Cytokeratin-5 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
Cytokeratin-5 Antibody (C-term) - Protein Information | |
| Name KRT5 | |
Cytokeratin-5 Antibody (C-term) - Application data
-
A. Western blot analysis on A431 cell lysate using anti-CK-5 RabMAb (Cat. #AJ1227c), dilution1:10,000
-
B. Immunohistochemical analysis of paraffin-embedded human transitional urinary bladder carcinoma using anti-CK5RabMAb.(Cat. #AJ1227c).
-
C. Immunofluorescent staining of A431 cells using anti-CK-5 RabMAb (Cat. #AJ1227c).
Cytokeratin-5 Antibody (C-term) - Related products
AT2660a: KRT5 Antibody (monoclonal) (M08)
AO1114a: Cytokeratin 5 Antibody
AO1115a: Cytokeratin (Pan) Antibody
AO1256a: Cytokeratin 5 Antibody
AO1269a: Cytokeratin(Pan) Antibody
AJ1227a: Cytokeratin-5 Antibody
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Keratins are a family of structurally related proteins that form the intermediate filament cytoskeleton in epithelial cells. The 58-kD keratin CK-5 is highly similar to other type II keratins and less similar to type I keratins and other intermediate filament proteins. The 58-kD keratin is regulated by retinoids in several tissues and is one of four keratins abundantly expressed in epidermal keratinocytes, where it may be important in maintaining structural integrity of the integument (1). Keratin 5 (CK-5) mRNA and protein are shown to be expressed in normal mammary epithelial cells in culture and are absent from tumor-derived cell lines. This makes CK-5 an important marker in the tumorigenic process, distinguishing normal from tumor cells, and decreased CK-5 expression correlates with tumorigenic progression (2). Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by progressive and disfiguring reticulate hyperpigmentation of the flexures. Loss of function of CK-5 suggests a crucial role for keratins in the organization of cell adhesion, melanosome uptake, organelle transport, and nuclear anchorage (3).
REFERENCES
1. Eckert RL, et al. DNA 7(5):337-45, 1988.
2. Trask DK, et al. Proc Natl Acad Sci 87(6)2319-23, 1990
3. Betz RC, et al. Am J Hum Genet 78(3):510-9, 2006.